Research Institute

Human Investigation Committee

RESEARCH WAIVER OF AUTHORIZATION

Form required when searching records to identify potential research subjects, or conducting data collection study.

HIPAA Requirements to Review Patient Data without Patient Consent

The Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) have made provisions to the Health Insurance Portability and Accountability Act (HIPAA) that establishes the conditions under which protected health information (PHI) may be used. This form is required to protect patient confidentiality rights when there is a need to view patient information via charts, computer databases or other recorded information sources when recruiting and locating potential subjects.

1. Please check one item below as it applies:

To accompany an HIC Initial Application
To accompany an Expedited review for Data collection Form
To accompany an HIC Exemption Status Request

2.

HIC #: / (If applicable)
Protocol Title : / (be certain the project title and this title match)

3. I assure the Human Investigation Committee that the following apply to this research proposal:

·  The PHI being used involves no more than minimal risk.

·  The alteration or waiver will not adversely affect the privacy rights and welfare of the individuals.

·  The research could not practicably be conducted without alteration or waiver; or without access to and use of the PHI.

·  The privacy risks to individuals whose PHI is to be used or disclosed are reasonable in relation to the anticipated benefits to the individuals (if any), and the importance of the knowledge that may reasonably be expect to result from the research.

·  The PHI will not be reused or disclosed to any other person or entity, except as required by law.

4.  Describe your plan to protect the identifier from improper use and disclosure.

a / How and where will data be stored?
Password protected computer
Encrypted flash drive
Secured/locked department office CHECK ALL THAT APPLY
Other:
NA Exempt study no identifiers
b / Who will have access to the patient identifiers?
Key personnel listed on the study roster
Sponsor
Federal agencies CHECK ALL THAT APPLY
Other:
NA Exempt study no identifiers

5.  Describe your plan to destroy the identifier at the earliest opportunity. All lists generated with patient identifiers, (e.g. name, medical record number) used to locate potential subjects, must be destroyed.

a / Describe plan to destroy list with patient identifiers:
Shredding of paper documents
Deletion of electronic data CHECK ALL THAT APPLY
NA Exempt study no identifiers
b / The list of identifiers will be destroyed:
Upon manuscript acceptance
Study completion
At the determination of the sponsor
At the time of consent
When deemed ineligible CHECK ALL THAT APPLY
Upon declining participation
NA Exempt study no identifiers

______

Principal Investigator Name - Printed Principal Investigator Signature Date

______

HIC Chairperson Approval Date

1

Wavier of Authorization Form Revised 4/18/12